Tag Archives: Marco Taglietti

Gedeon Richter Plc. and Forest Laboratories, Inc. announce positive Phase IIb studies for cariprazine in both bipolar depression and major depressive disorder

Posted on 1, April 2014 by

Budapest and New York, 1-4-2014 — /EuropaWire/ — Gedeon Richter Plc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive topline results from a Phase IIb trial evaluating the efficacy and safety of the investigational antipsychotic cariprazine in patients with bipolar depression. … Read the full press release →

Posted in Business, Hungary, Pharma & Biotech, Science

Tagged , , , , , , ,